PRDM1 restricts bladder cancer progression and enhances chemosensitivity by suppressing OTUD6A-mediated deubiquitination of CDC6
Jianfeng Cui, Shouzhen Chen, Xiaochen Liu, Xuewen Jiang, Guangzhou Cheng, Zhifeng Liu, Hui Zhao, Yaofeng Zhu, Benkang Shi, Yongxin Zou

TL;DR
PRDM1 limits bladder cancer growth and improves treatment response by reducing CDC6 levels through suppression of OTUD6A activity.
Contribution
The study identifies a PRDM1-OTUD6A-CDC6 regulatory axis in bladder cancer, revealing a novel tumor suppressive mechanism.
Findings
PRDM1 is downregulated in bladder cancer tissues and mouse models.
PRDM1 suppresses cell proliferation and enhances chemosensitivity by inhibiting OTUD6A-mediated CDC6 deubiquitination.
PRDM1 expression is negatively correlated with OTUD6A and CDC6 in bladder cancer tissues.
Abstract
PR domain zinc finger protein 1 (PRDM1) functions as a critical transcriptional repressor. The role of PRDM1 in various tumors is controversial, and its specific mechanism in bladder cancer (BCa) remains unclear. In the present study, we demonstrated that PRDM1 expression is downregulated in both human BCa tissues and BBN-induced mouse models of BCa. Gain- and loss-of-function experiments revealed that PRDM1 delays cell cycle progression, suppresses BCa cell proliferation, and enhances chemosensitivity, whereas PRDM1 knockdown promotes cell proliferation and induces chemoresistance. Ovarian tumor deubiquitinase 6 A (OTUD6A) is a deubiquitinating enzyme that prevents the proteasomal degradation of CDC6. PRDM1 directly binds to the OTUD6A promoter and suppresses its transcription, thereby reducing CDC6 deubiquitination and promoting its degradation. Knockdown of CDC6 or OTUD6A abrogates…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsUbiquitin and proteasome pathways · TGF-β signaling in diseases · Ferroptosis and cancer prognosis
